Personnaliser

OK

Mondial 2026 : 50? offerts* dès 499? d'achat sur les télévisions, vidéoprojecteurs et barres de son avec le code : TV50

En profiter

Alternative Splicing and Cancer -

Note : 0

0 avis
  • Soyez le premier à donner un avis

Vous en avez un à vendre ?

Vendez-le-vôtre

247,99 €

Produit Neuf

  • Ou 62,00 € /mois

    • Livraison à 0,01 €
    • Livré entre le 26 mai et le 2 juin
    Voir les modes de livraison

    RiaChristie

    PRO Vendeur favori

    4,9/5 sur + de 1 000 ventes

    Brand new, In English, Fast shipping from London, UK; Tout neuf, en anglais, expédition rapide depuis Londres, Royaume-Uni;ria9781032196596_dbm

    Publicité
     
    Vous avez choisi le retrait chez le vendeur à
    • Payez directement sur Rakuten (CB, PayPal, 4xCB...)
    • Récupérez le produit directement chez le vendeur
    • Rakuten vous rembourse en cas de problème

    Gratuit et sans engagement

    Félicitations !

    Nous sommes heureux de vous compter parmi nos membres du Club Rakuten !

    En savoir plus

    Retour

    Horaires

        Note :


        Avis sur Alternative Splicing And Cancer de Format Relié  - Livre Beaux arts

        Note : 0 0 avis sur Alternative Splicing And Cancer de Format Relié  - Livre Beaux arts

        Les avis publiés font l'objet d'un contrôle automatisé de Rakuten.


        Présentation Alternative Splicing And Cancer de Format Relié

         - Livre Beaux arts

        Livre Beaux arts - 01/05/2024 - Relié - Langue : Anglais

        . .

      • Editeur : Crc Press
      • Langue : Anglais
      • Parution : 01/05/2024
      • Format : Moyen, de 350g à 1kg
      • Nombre de pages : 212
      • Expédition : 476
      • Dimensions : 24.0 x 16.1 x 1.6
      • ISBN : 9781032196596



      • Résumé :
        .

        Biographie:

        Muzafar A. Macha, currently an Assistant Professor and Ramalingaswami Fellow at Watson-Crick Centre for Molecular Medicine, IUST, Kashmir, India, possesses a strong background in Biochemistry, Head and Neck Cancers (HNCs), and therapeutic modalities development. He previously served as a postdoctoral fellow and later as an Assistant Professor at the University of Nebraska Medical Centre (UNMC), leading an independent HNC research group. His notable contributions, recognized with multiple awards, include the identification of deregulated signaling pathways and innovative therapeutic strategies, published in esteemed journals.

        Ajaz A. Bhat, a staff scientist at Sidra Medicine, Qatar, has an extensive background in peptide-based vaccine development, deregulated signaling pathways, and drug targets for various cancers. After earning his Ph.D. from AIIMS, India, he undertook postdoctoral training at Vanderbilt University Medical School, USA, expanding his understanding of colorectal, gastric, and esophageal cancers. His high-impact research, published in prestigious journals, earned him recognition as an outstanding researcher, and he actively serves on several immunology and cancer societies' editorial and review boards.

        Surinder Kumar Batra, Chair of the Biochemistry and Molecular Biology Department at the University of Nebraska Medical Center (UNMC), USA, and Associate Director at Buffett Cancer Center, is renowned for his work on pancreatic cancer pathogenesis. His research focuses on mucins, glycoproteins with potential diagnostic and therapeutic applications. He has developed several genetically engineered models for cancer progression and received US patents on diagnostics and antibodies. With over 400 international peer-reviewed publications, he has trained 100+ scholars.

        Sommaire:

        Preface 1. Alternative Splicing and Human Diseases 2. Mechanism of RNA Splicing 3. Alternative Splicing: A New Cancer Hallmark 4. Deregulated Spliceosome and Splice Variants in Cancers 5. Deregulated Oncogenic Signaling Pathway(s) and Alternative Splicing 6. Alternative Splicing and Metastasis 7. Role of Splice Variant of Pyruvate Kinase M2 (PKM2) in Cancer Metabolism 8. Alternative Splicing and Immune Surveillance 9. Therapeutic Targeting of Alternative Splicing in Cancers 10. Alternative Splicing in Cancer Drug Resistance 10. A Systematic Evaluation of Alternative Splicing and Cancer: A Review Index.

        Détails de conformité du produit

        Consulter les détails de conformité de ce produit (

        Personne responsable dans l'UE

        )
        Le choixNeuf et occasion
        Minimum5% remboursés
        La sécuritéSatisfait ou remboursé
        Le service clientsÀ votre écoute
        LinkedinFacebookTwitterInstagramYoutubePinterestTiktok
        visavisa
        mastercardmastercard
        klarnaklarna
        paypalpaypal
        floafloa
        americanexpressamericanexpress
        Rakuten Logo
        • Rakuten Kobo
        • Rakuten TV
        • Rakuten Viber
        • Rakuten Viki
        • Plus de services
        • À propos de Rakuten
        Rakuten.com